Alta Sciences

MAY 30, 2025

Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs iianiro Fri, 05/30/2025 - 20:00 Publication ASCP_Poster_Development_of_the_Subject-Rated_Comprehensive_Drug_Withdrawal_Scale_(CDWS)_to_Evaluate_the_Physical_Dependence_Potential_of_Investig.

Drugs

BioPharma Drive: Drug Pricing

MAY 30, 2025

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly extended survival, which will be necessary to support an FDA submission.

FDA

Alta Sciences

MAY 30, 2025

Navigating the Unchartered Territory of Assessing Psychedelics in Human Abuse Potential Studies iianiro Fri, 05/30/2025 - 20:00 Publication ASCP_Poster_Navigating_the_Unchartered_Territory_of_Assessing_Psychedelics_in_Human_Abuse_Potential_Studies.

Science Daily: Pharmacology News

MAY 30, 2025

Singing to your infant can significantly boost the baby's mood, according to a recent study. Around the world and across cultures, singing to babies seems to come instinctively to caregivers. Now, new findings support that singing is an easy, safe, and free way to help improve the mental well-being of infants. Because improved mood in infancy is associated with a greater quality of life for both parents and babies, this in turn has benefits for the health of the entire family, the researchers sa

Research

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

BioPharma Drive: Drug Pricing

MAY 30, 2025

Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner companies.

Trials

Science Daily: Pharmacology News

MAY 30, 2025

A series of studies sheds light on the origins and characteristics of intermediate-mass black holes.

BioPharma Drive: Drug Pricing

MAY 30, 2025

Keros will also stop work on a cardiovascular disease drug. Elsewhere, Stealth Biotherapeutics and Taysha Gene Therapies each think they've found a path to FDA approval.

FDA Approval

Perficient: Drug Development

MAY 30, 2025

Salesforces acquisition of Informatica is a big move and a smart one. It brings together the worlds #1 AI CRM with a top name in enterprise cloud data management. Together, theyre taking on a challenge every business faces turning scattered, messy data into something clean, connected, and ready to power AI. Whats Next for Data Cloud To understand why Salesforces acquisition of Informatica matters, it helps to look at where Data Cloud is headed.

Government

Alta Sciences

MAY 30, 2025

Practical Considerations for the Evaluation of Physical Dependence and Drug Withdrawal for Novel CNS-Active Drugs in Clinical Trials iianiro Fri, 05/30/2025 - 20:00 Publication ASCP_Poster_Practical_Considerations_for_the_Evaluation_of_Physical_Dependence_and_Drug_Withdrawal_for_Novel_CNS-Active_Drugs_in_Clinical_Trials.

Clinical Trials

Perficient: Drug Development

MAY 30, 2025

Join Perficient at Kscope25 in Grapevine, Texas, from June 15-19, 2025! As a premier educational conference for Oracle technology users, Kscope25 promises an unparalleled experience with over 250 technical sessions, hands-on training, and all-day symposiums. This event is a unique opportunity to connect with Oracle experts, learn from industry leaders, and discover innovative solutions to your most pressing challenges.

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Drug Channels

MAY 30, 2025

Todays guest post comes from Aaron Crittenden, President of Rx Marketplace at GoodRx. Aaron introduces us to GoodRx Community Link , a new offering from GoodRx that allows independent pharmacies to contract directly with GoodRx. To learn about GoodRx Community Link, register for GoodRxs free webinar on either June 3, 2025, or June 4, 2025. Both webinars will be held at 11:00 a.m.

Pharmacy

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new study says.About 208 of every 100,000 U.S. young adults were using pre-exposure prophylaxis, or PrEP.

PPD

MAY 30, 2025

The high-stakes world of small and emerging biotechs is extremely competitive. Transforming a clinical product from ideation to market demands significant resources and deep expertise to efficiently manage and enable success, especially in todays landscape. Without this expertise, hurdles such as regulatory setbacks, protocol changes and wasted resources frequently arise.

Clinical Trials

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 -- As of today, the total measles case count in the United States is 1,088, according to the U.S. Centers for Disease Control and Prevention. Texas, which saw the nation's largest outbreak during the late winter of 2024 and.

Disease

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

New Drug Approvals

MAY 30, 2025

Lotilaner CAS 1369852-71-0 Credelio XDEMVY lotilanerum 596.8 g/mol, C 20 H 14 Cl 3 F 6 N 3 O 3 S TP 03 TP-03 TP03 3-methyl- N -[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-5-[(5 S )-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4 H -1,2-oxazol-3-yl]thiophene-2-carboxamide FDA Xdemvy , 7/25/2023, To treat Demodex blepharitis Drug Trials Snapshot Lotilaner , sold under the brand name Xdemvy , is an ectoparasiticide (anti-parasitic) medication used for the treatment of blepharitis (inflammation of th

FDA Approval

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine causing sharp criticism from doctors and other experts.The announcement came Tuesday from Health and Human Services.

Vaccine

thought leadership

MAY 30, 2025

For non-European pharmaceutical companies, expanding into the European market is both an exciting opportunity and a formidable challenge. While the potential for growth is significant, so too are the complexities of achieving European marketing authorization. The regulatory, logistical, and cultural differences between European countries and countries outside of the region can hinder progress, increase costs, and delay time-to-market.

Marketing

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 The mentally scarred, deeply depressed combat veteran is an indelible stereotype promoted by movies and TV.The post-traumatic stress and despair that some suffer following military deployment have prompted concerns that s.

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Perficient: Drug Development

MAY 30, 2025

I have been writing about the Redwood Experience with Supply Chain Management, especially with the Inventory Management. Oracle has gone all-in with Redwood Experience in Inventory Management in 25B. The 25 Inventory Management readiness documentation lists all new features and how to use them, so I will not repeat this greatly written document: [link] For the previous features in Redwood, please consider visiting the Readiness documentation: [link] This page is my personal favorite since it pro

International

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 About 2 of 5 smokers in the U.S. suffer from some form of disability, a new study says.And in 1 of 7, their disability is so severe it interferes with their daily lives, researchers report.The prevalence of disability among a.

Research

Drug Target Review

MAY 30, 2025

Drug Target Review had the pleasure of attending SLAS Europe 2025 in Hamburg and what we saw was no mere showcase of cutting-edge tools, but a clear snapshot of where drug discovery is heading. With smarter systems, usable AI , streamlined automation, and far better ways to manage the ever-growing complexity of scientific data , the event opened eyes to the tangible technology that is opening doors to therapeutic solutions.

Small Molecule

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 A parents instincts regarding their childs health usually are right on the money, even when theyve taken the child to an ER, a new study says.Parental worry over a kids deteriorating health strongly predicts how criticall.

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 Skies choked with wildfire smoke can affect peoples heart and lung health for up to three months afterwards, a new study says.The particle pollution created by wildfires continues to increase peoples risk of hospitalization.

Hospitals

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 Hormel Foods is recalling more than 256,000 pounds of its Dinty Moore Beef Stew amid reports that wood fragments were found in some cans, according to U.S. health officials.The U.S. Department of Agriculture's Food Safety and.

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 Dr. Robert Jarvik, the man behind the worlds first permanent artificial heart used in a human, has died. He was 79, The New York Times reported.His wife, writer Marilyn vos Savant, said he died Monday at their home in Man.

Drugs.com

MAY 30, 2025

FRIDAY, May 30, 2025 Twice as many Americans now face the increased risk of death that comes from having both high blood pressure and type 2 diabetes, a new study reports.About 12% of the U.S. population had high blood pressure and type 2 d.